FdaApplication
ANDA 201951
Identifiers
- fda_app_no: ANDA201951
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS ELIZABETH LLC |
| application_type | ANDA |
| approval_date | 2013-07-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | EQ 3MG BASE | TABLET;ORAL |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | EQ 6MG BASE | TABLET;ORAL |
2 products